Patents by Inventor Jan Snoeys

Jan Snoeys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CAPSID ASSEMBLY MODULATOR DOSING REGIMEN
    Publication number: 20210260025
    Abstract: The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.
    Type: Application
    Filed: March 16, 2021
    Publication date: August 26, 2021
    Inventors: Koen VANDYCK, Oliver LENZ, Claire Elisabeth BALMAIN, Jan SNOEYS, Joris Jozef VANDENBOSSCHE, Dominique Josiane W. VERSTRAETE, Jeysen Zivan YOGARATNAM, Maria JANSENS, Frederic VAN DYCKE
  • Capsid assembly modulator dosing regimen
    Patent number: 10973801
    Abstract: The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: April 13, 2021
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Koen Vandyck, Oliver Lenz, Claire Elisabeth Balmain, Jan Snoeys, Joris Jozef Vandenbossche, Dominique Josiane W. Verstraete, Jeysen Zivan Yogaratnam, Maria Jansens, Frederic Van Dycke
  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20200332297
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and methods of administering same. The HBV RNAi agents and CAMs are administered in ratios to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Michael BIERMER, Ronald KALMEIJER, Oliver LENZ, Maria Gloria BEUMONT-MAUVIEL, Jan SNOEYS, Kenneth Alan SIMMEN
  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20200330499
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and methods of administering same. The HBV RNAi agents and CAMs are administered in ratios to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Michael BIERMER, Ronald KALMEIJER, Oliver LENZ, Maria Gloria BEUMONT-MAUVIEL, Jan SNOEYS, Kenneth Alan SIMMEN
  • CAPSID ASSEMBLY MODULATOR DOSING REGIMEN
    Publication number: 20190282542
    Abstract: The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.
    Type: Application
    Filed: March 13, 2019
    Publication date: September 19, 2019
    Inventors: Koen VANDYCK, Oliver LENZ, Claire Elisabeth BALMAIN, Jan SNOEYS, Joris Jozef VANDENBOSSCHE, Dominique Josiane W. VERSTRAETE, Jeysen Zivan YOGARATNAM, Maria JANSENS, Frederic VAN DYCKE
  • COMBINATION OF A MACROCYCLIC PROTEASE INHIBITOR OF HCV, A NON-NUCLEOSIDE HCV INHIBITOR AND RITONAVIR
    Publication number: 20150209366
    Abstract: The present invention relates to a combination of a macrocyclic NS3/4A protease inhibitor of HCV, a HCV NS5B polymerase inhibiting non-nucleoside and ritonavir.
    Type: Application
    Filed: August 30, 2013
    Publication date: July 30, 2015
    Inventors: Marie-Claude Rouan, Jan Snoeys